SRD5A2 Antibody (Center) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P31213 |
---|---|
Other Accession | NP_000339.2 |
Clone Names | 90713201 |
Gene ID | 6716 |
---|---|
Other Names | 3-oxo-5-alpha-steroid 4-dehydrogenase 2, 5 alpha-SR2, SR type 2, Steroid 5-alpha-reductase 2, S5AR 2, Type II 5-alpha reductase, SRD5A2 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | SRD5A2 |
---|---|
Function | Converts testosterone (T) into 5-alpha-dihydrotestosterone (DHT) and progesterone or corticosterone into their corresponding 5- alpha-3-oxosteroids. It plays a central role in sexual differentiation and androgen physiology. |
Cellular Location | Microsome membrane; Multi-pass membrane protein. Endoplasmic reticulum membrane; Multi-pass membrane protein |
Tissue Location | Expressed in high levels in the prostate and many other androgen-sensitive tissues |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene encodes a microsomal protein expressed at highlevels in androgen-sensitive tissues such as the prostate. Theencoded protein is active at acidic pH and is sensitive to the4-azasteroid inhibitor finasteride. Deficiencies in this gene canresult in male pseudohermaphroditism, specifically pseudovaginalperineoscrotal hypospadias (PPSH).
References
Thigpen, A.E., et al. N. Engl. J. Med. 327(17):1216-1219(1992)Thigpen, A.E., et al. J. Clin. Invest. 90(3):799-809(1992)Labrie, F., et al. Endocrinology 131(3):1571-1573(1992)Andersson, S., et al. Nature 354(6349):159-161(1991)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.